AT1 receptor antagonism promotes bone loss attenuation in experimental periodontitis, blocks inflammatory mediators, and upregulates antioxidant enzymes and bone formation markers.
Thiago José DionísioGabriela P SouzaBella L Colombini-IshikiriamaThais F GarbieriViviane A ParisiGabriela de Moraes OliveiraIsadora P CanoCamila O RodiniSandra H P OliveiraAndrew S GreeneCarlos Ferreira Dos SantosPublished in: Journal of periodontology (2019)
AT1 receptor modulates EP progression.